Cargando…

A Validation Study of a Noninvasive Lactate Threshold Device

The lactate threshold is considered a key marker of endurance exercise performance and identification of this threshold is important in writing an exercise training program. Unfortunately, assessment of the lactate threshold has traditionally required venous or capillary blood samples and a speciali...

Descripción completa

Detalles Bibliográficos
Autores principales: MCMORRIES, REBECCA M., JOUBERT, DUSTIN P., JONES, ERIC J., FARIES, MARK D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Berkeley Electronic Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355126/
https://www.ncbi.nlm.nih.gov/pubmed/30761197
_version_ 1783391300900356096
author MCMORRIES, REBECCA M.
JOUBERT, DUSTIN P.
JONES, ERIC J.
FARIES, MARK D.
author_facet MCMORRIES, REBECCA M.
JOUBERT, DUSTIN P.
JONES, ERIC J.
FARIES, MARK D.
author_sort MCMORRIES, REBECCA M.
collection PubMed
description The lactate threshold is considered a key marker of endurance exercise performance and identification of this threshold is important in writing an exercise training program. Unfortunately, assessment of the lactate threshold has traditionally required venous or capillary blood samples and a specialized meter to assess blood lactate concentrations. Recently, a consumer grade, non-invasive device was developed to determine muscle oxygenation and estimate the lactate threshold. PURPOSE: The aim of this study was to assess the validity of a noninvasive lactate threshold device (NID) to determine lactate threshold heart rate (LTHR). METHODS: Twenty-one recreational athletes (14 females, 39 ± 7 years, 29.1 ± 5.2% fat, 37.8 ± 6.0 ml·kg(−1)·min(−1); 7 males, 42 ± 9 years, 16.8 ± 2.2% fat, 45.9 ± 6.4 ml·kg(−1)·min(−1)) completed a personalized graded exercise test on a treadmill. All participants wore the NID and blood lactate samples were taken at the end of 3-minute stages. LTHR was then calculated using two traditional methods (4 mmol/L and >1 mmol/L increase) and compared against the same heart rate values calculated by the NID. RESULTS: No significant differences (p = .87) were found in LTHR between the NID and the traditional lactate methods (NID: 167 ± 9 bpm, 4 mmol/L: 167 ± 12 bpm, >1 mmol/L: 167 ± 12 bpm). CONCLUSIONS: This study provides preliminary support for the validity of the NID for estimation of LTHR.
format Online
Article
Text
id pubmed-6355126
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Berkeley Electronic Press
record_format MEDLINE/PubMed
spelling pubmed-63551262019-02-11 A Validation Study of a Noninvasive Lactate Threshold Device MCMORRIES, REBECCA M. JOUBERT, DUSTIN P. JONES, ERIC J. FARIES, MARK D. Int J Exerc Sci Original Research The lactate threshold is considered a key marker of endurance exercise performance and identification of this threshold is important in writing an exercise training program. Unfortunately, assessment of the lactate threshold has traditionally required venous or capillary blood samples and a specialized meter to assess blood lactate concentrations. Recently, a consumer grade, non-invasive device was developed to determine muscle oxygenation and estimate the lactate threshold. PURPOSE: The aim of this study was to assess the validity of a noninvasive lactate threshold device (NID) to determine lactate threshold heart rate (LTHR). METHODS: Twenty-one recreational athletes (14 females, 39 ± 7 years, 29.1 ± 5.2% fat, 37.8 ± 6.0 ml·kg(−1)·min(−1); 7 males, 42 ± 9 years, 16.8 ± 2.2% fat, 45.9 ± 6.4 ml·kg(−1)·min(−1)) completed a personalized graded exercise test on a treadmill. All participants wore the NID and blood lactate samples were taken at the end of 3-minute stages. LTHR was then calculated using two traditional methods (4 mmol/L and >1 mmol/L increase) and compared against the same heart rate values calculated by the NID. RESULTS: No significant differences (p = .87) were found in LTHR between the NID and the traditional lactate methods (NID: 167 ± 9 bpm, 4 mmol/L: 167 ± 12 bpm, >1 mmol/L: 167 ± 12 bpm). CONCLUSIONS: This study provides preliminary support for the validity of the NID for estimation of LTHR. Berkeley Electronic Press 2019-01-01 /pmc/articles/PMC6355126/ /pubmed/30761197 Text en
spellingShingle Original Research
MCMORRIES, REBECCA M.
JOUBERT, DUSTIN P.
JONES, ERIC J.
FARIES, MARK D.
A Validation Study of a Noninvasive Lactate Threshold Device
title A Validation Study of a Noninvasive Lactate Threshold Device
title_full A Validation Study of a Noninvasive Lactate Threshold Device
title_fullStr A Validation Study of a Noninvasive Lactate Threshold Device
title_full_unstemmed A Validation Study of a Noninvasive Lactate Threshold Device
title_short A Validation Study of a Noninvasive Lactate Threshold Device
title_sort validation study of a noninvasive lactate threshold device
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355126/
https://www.ncbi.nlm.nih.gov/pubmed/30761197
work_keys_str_mv AT mcmorriesrebeccam avalidationstudyofanoninvasivelactatethresholddevice
AT joubertdustinp avalidationstudyofanoninvasivelactatethresholddevice
AT jonesericj avalidationstudyofanoninvasivelactatethresholddevice
AT fariesmarkd avalidationstudyofanoninvasivelactatethresholddevice
AT mcmorriesrebeccam validationstudyofanoninvasivelactatethresholddevice
AT joubertdustinp validationstudyofanoninvasivelactatethresholddevice
AT jonesericj validationstudyofanoninvasivelactatethresholddevice
AT fariesmarkd validationstudyofanoninvasivelactatethresholddevice